This was so well-explained, I feel much more confident now.
@CometChaser-q9z17 күн бұрын
useful
@vichekahouy-h2p20 күн бұрын
thank you
@aryamanjha9380Ай бұрын
I had to watch an ad just to like the video
@zomviesАй бұрын
Horribly explained, dont ever make yt videos again
@Eva-vx3cgАй бұрын
You have a mistake in your video. The one minute mark, you show DNA as having mirror image strands. Actually, DNA is anti-parallel, so one strand is opposite in relation to the other. It would be good to fix! Otherwise, really good.
@HiMy-p7oАй бұрын
Tysm
@bumonthecorner13Ай бұрын
this didnt help at all just got me more confused like at 0:40 when it says the first wo show a child who has inherited the father's x chromosome and so will be a girl..... why does that guarantee that.
@GenomicsEducation28 күн бұрын
Thanks for reaching out. To directly answer your question on why we say the child will be female when inheriting the X-chromosome from her dad, this is because males have both ‘X’ and ‘Y’ chromosomes (XY), while females have two ‘X’ chromosomes (XX). Therefore, should the dad provide an ‘X’ chromosome at conception, it’s expected that the baby will be born XX (one X from the dad and the other X from the mum) and so will be female. Should the dad provide a ‘Y’ chromosome at conception, it’s expected that the baby will be born XY (the Y from the dad and the X from the mum) and so will be male. Still uncertain? For a different take on this topic, see this BBC Bitesize article on sex determination: www.bbc.co.uk/bitesize/guides/zcdfmsg/revision/5 Thanks again for your comment and hope the above helps.
@colinrussell6373Ай бұрын
Very helpful, thanks! 😃
@inkmetalpanda2 ай бұрын
Thank you for sharing your story! We need to push help from the professionals a lot more because kick shouldn't have been a factor esp since this was considered a male dominant disease. Sending healing thoughts and strength to you and your family from an affected Fabry Female ❤
@aqsasafdar21112 ай бұрын
IAM 7 BUT I CAN LEARN IT LIE 🌸🎶❤️🔥
@NicholasSleeis2 ай бұрын
Shine light on how one with Silver-Russell Syndrome can beat the plight of severe hip/ leg/ ankle pain that keeps one awake most nights
@HajaJallow-e5f3 ай бұрын
thank you sir I have to do my home work ❤❤❤❤❤❤❤❤❤❤❤
@karinajones11213 ай бұрын
Thank you for this.
@weemissile3 ай бұрын
Please ask Dr Patterson to get a better microphone. I can barely understand him.
@93prodbyaj3 ай бұрын
Cant understand this bri ish yute
@ThinkingInTheAir4 ай бұрын
please stop playing such dramatic music in every video it's really annoying just leave the music out and say the words. All of these videos are like this..I want to hear dais without music
@vamsiraj46604 ай бұрын
Concept is cleared with better explanation in shorter tenure
@patrickmoan40864 ай бұрын
Fantastic summary of the fundamentals. Much appreciated.
@hamzaothman94344 ай бұрын
where i can find the presentation slides?
@GenomicsEducation4 ай бұрын
Hi and thank you for your query. This presentation's slides aren't available for download. Should you wish to re-visit this presentation in the future, then consider bookmarking our HPO terms explainer article, which also has this video, at: www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/the-human-phenotype-ontology
@enzopaolozavalacancho2595 ай бұрын
2:28 Does the reference sequence/genome is also obtained by WGS?
@GenomicsEducation4 ай бұрын
Thank you for your question. Whole genome sequencing (WGS) refers to DNA sequencing of an organism's entire genome. So technically yes, WGS was done to create the very first human reference genome, which was published in the early 2000s. (However, it was not sequenced all in one go like scientists do nowadays.) Today, scientists can compare a patient's genome to this reference genome (which has since seen updates) to help understand the genomic basis of their condition. Thank you again and we hope this helps. If you'd like to find out more, then please see our 2017 blog post which looks at the reference genome, where it came from and why it needs continuous updates: www.genomicseducation.hee.nhs.uk/blog/reference-genome-defining-human-difference/
@sidhik_7785 ай бұрын
whoop yeh super bro❤❤
@kemalturgut91275 ай бұрын
How do computers identify which nucleotides consists of what bases and where are they located etc. ? Im begging for an answer
@GenomicsEducation4 ай бұрын
Thank you for your comment. To answer your question: There are many ways to sequence DNA. How computers identify what DNA base is where depends on which way is used. In Sanger sequencing - one of the first ways invented - laboratory processing tags each base with a different fluorescent marker. The computer then looks for fluorescent signals from the DNA. For example, when the computer detects a green-fluorescent signal, it knows that there is an adenine DNA base located there. When it detects a blue-fluorescent signal, it knows that there is a guanine DNA base. In this way, the computer can ‘read’ DNA and tell us the order of bases. This is simplified explanation. For a more thorough explanation, please see this video by ClevaLab, which provides a fun look at Sanger sequencing: kzbin.info/www/bejne/jmqYZ2mvfpeWeNE We hope this helps. Thank you again for the question.
@kemalturgut91274 ай бұрын
@@GenomicsEducation this was a great explanation. Thank you. And how do fluorescent markers bind to the specific parts of the DNA to reveal where the light is coming from ? Do you make specific probes in labs and hybrid it with fluorescent molecules ? Im genuinely curious
@GenomicsEducation4 ай бұрын
@@kemalturgut9127 Thank you for your reply and question on fluorescent markers in the context of DNA sequencing. The technology is best understood visually. So, take a look at 'Sanger DNA Sequencing, From Then to Now' on ClevaLab's channel to see the whole process in an understandable way: kzbin.info/www/bejne/jmqYZ2mvfpeWeNE
@nusratafrin8985 ай бұрын
Thanks for sharing
@europhile26585 ай бұрын
Is there a sample report online?
@GenomicsEducation5 ай бұрын
Thank you for your query. While we don't have an example sample report to hand, you may find the information provided within our online rare disease and solid tumours courses of use. There are parts within about genomic reports, including what you might expect to see. Solid tumours course: www.futurelearn.com/courses/genomics-in-the-nhs-a-clinicians-guide-to-genomic-testing-for-cancer-solid-tumours? Rare disease course: www.futurelearn.com/courses/genomics-in-the-nhs-a-clinicians-guide-to-genomic-testing-for-cancer-solid-tumours? All our educational materials (many are free) may be found online at: www.genomicseducation.hee.nhs.uk/education/ We hope this helps and thank you for taking the time to watch our film.
@AfaanwazirKhan6 ай бұрын
Thanks,very outstanding video
@Hehehehe7v6 ай бұрын
Just one question 🙋 you guys said that data you we're talking about is in statistical format and require specialist to make that simple and explain to non experts but what if we put that machine data to an ai and ask it to simplify it to child level. I want to be bioinformatics too but I guess I am too paranoid about its replacement. Can you help me?
@GenomicsEducation5 ай бұрын
Many thanks for your comment. There are several limitations in using AI to simplify complex medical problems: statistical models are inherently complex and difficult to reduce to simple terms without losing accuracy; AI struggles to understand the nuances of medical data, often leading to oversimplifications or incorrect conclusions; AI models can be biased, resulting in misleading interpretations; finally, human expertise is crucial for accurately conveying complex medical information, a task AI cannot fully replicate. We hope this provides a satisfactory answer to your question. Many thanks again and thanks also for taking the time to watch the film.
@Hehehehe7v5 ай бұрын
@@GenomicsEducation that's really helpful thanks a million times for it
@akhilthota38607 ай бұрын
back ground music is disturbing otherwise the video in very informative and good
@ransomndubuisinnah9747 ай бұрын
DNA
@ArreyNeeh7 ай бұрын
Good explanation 👏
@casey-zd5mj7 ай бұрын
you've been genomed
@Nexus-Otaku-A-507 ай бұрын
Thanks for explaining 😊😊😊😊
@Suresh-sk3vu7 ай бұрын
Super
@basic-ly8 ай бұрын
Thanks! Great video! 😇
@renzo28428 ай бұрын
thank you, sir. I have an exam regarding this concept in two days
@sanjaisrao4848 ай бұрын
Thank you, Excellent explaination
@pml111110 ай бұрын
Yes, genetics medicine is bittersweet this days. Knowledge but not treatments all the times.
@George-rq1yp Жыл бұрын
damn, best presenter i have seen!
@childspecialist-dr.akumtos4383 Жыл бұрын
Thank you..... excellent presentation 😊
@yungbloodas3789 Жыл бұрын
Thank you so very much!
@mahnoorkhan5501 Жыл бұрын
Outclass explanation.... Like it
@Saed7630 Жыл бұрын
Excellent presentation!
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Start 04:50 Overview and webinar one recap 06:28 What are cancer mutational signatures and why are they important? 09:04 Mathematical concepts to define mutational signatures 12:38 What do mutational signatures look like (with examples)? 16:15 Extracting and checking mutational signatures 20:23 Caveats to extraction 24:10 Assigning mutational signatures to samples 29:12 Examples 33:22 Clinically relevant signatures summary table 35:22 Mutational signatures: HR deficiency 41:17 Mutational signatures: MMR deficiency 45:12 Mutational signatures: POLE dysregulation 49:05 Mutational signatures: MBD4 mutated cancers 51:03 Mutational signatures: NTHL1 loss 51:18 Mutational signatures: Biallelic MUTYH mutation 55:10 Mutational signatures: Long tandem duplicators 56:12 Mutational signatures to watch out for 57:36 Acknowledgements and Q&A
@sarahvegter790 Жыл бұрын
What if the father has the condition and the mother is a carrier of the trait, can their daughter have the condition?
@GenomicsEducation Жыл бұрын
Hi and thank you for the question. Any daughter from this couple will always inherit the X chromosome with the genetic variant for the condition from her father, but she may or may not inherit the X chromosome with the genetic variant for the condition from her mother. From this couple: - for daughters, 50% will have the condition while 50% will be carriers for the condition (on average). - for sons, 50% will have the condition and 50% will not have the condition (on average).
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Welcome and introductions 02:05 Discovering the molecular background to Cystic Fibrosis 05:14 What is the genetics of CF? 07:49 Phenotypes seen in CF and patient prognosis 12:46 CFTR types overview 13:45 CFTR modulators and triple therapy 16:27 Ivacaftor - clinical trials, real-life data, patient experiences and costs 24:02 Double therapy - Orkambi and Symkevi outcome data, patient experiences and costs 28:15 Triple therapy - What did the Kaftrio clinical trials show? 31:53 Kaftrio is commissioned by NHS England in 2020 35:16 What are patients on Kaftrio experiencing? 38:00 The estimated Katrio cost to the NHS 40:36 Ethical and access considerations 43:13 Type-1 CFTR drug efforts - CRISPR and gene editing 45:34 Talk conclusions 46:30 Q&A and close
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Introductions and talk overview 01:56 What is cancer, to our genome? 07:20 How does a childhood cancer genome differ from that of an adult? 12:43 WGS, paediatric oncology and equitable access 16:22 Patient and parents' perspective and NHS service implications 20:11 100,000 genomes project and paediatric genomes 27:22 Case study 1: Treatment of a 10 year old with Wilms tumour-like genomic changes in RCC 31:09 Case study 2: 16 month old's tumour treatment decided after WGS 36:00 The 'live programme' at Cambridge 39:02 Case study 3: Baby with unknown mass achieves diagnosis 41:14 Conclusions on WGS in paediatric oncology 42:30 Wrap up and Q&A
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Introductions and talk overview 02:20 Learing objectives 03:05 What is target validation? 03:34 What is Open Targets? 05:10 What are orphan drugs? 06:49 How are the DDD project, DICIPHER database and DDG2P database related? 08:05 Motivation behind the repurposing drugs for rare disease algorithm. 10:48 Method 13:55 Results 16:30 Analysis of data 19:49 Real world example 1 - Penttinen-type premature aging syndrome 20:31 Real world example 2 - Hyperkalaemic periodic paralysis type 1 22:38 Real world example 3 - CLOVES 25:03 The future of repurposing dugs for rare disease 26:34 Acknowledgements and wrap up 28:00 Q&A